The US Food and Drug Administration (FDA) on Friday issued a question-and-answer guidance to provide clarity to manufacturers on reporting post-approval changes to disposable manufacturing material.
Morningstar: DifGen Pharmaceuticals LLC Receives USFDA Approval for Fluorometholone Ophthalmic Suspension, 0.1% - Expanding Its Complex Generic Portfolio
DifGen Pharmaceuticals LLC Receives USFDA Approval for Fluorometholone Ophthalmic Suspension, 0.1% - Expanding Its Complex Generic Portfolio
Drugmakers looking to make a change to the drug substance manufacturing process during an application’s post-approval period should consult the US Food and Drug Administration’s (FDA) new draft ...
Two forthcoming guidelines from the International Council on Harmonization (ICH) should make it easier to switch analytical methods for testing medicines post-approval and better manage lifecycle ...
MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug ...
In this post, we will take a closer look at the most common medical and non-medical causes of scalp itching. You’ll also learn how to recognize the symptoms of each condition, discover ways to minimize discomfort, and know when it is time to see a dermatologist for expert care.
An itchy scalp usually comes down to a handful of common causes, and most of them respond well to simple changes in your routine or over-the-counter products. The fix depends on what’s driving the itch, so identifying the likely culprit is the first step toward relief.
POST training videos are designed to assist law enforcement training managers and instructors in meeting specific training needs or legislative mandates for their agency.